1. Home
  2. LGND vs FSK Comparison

LGND vs FSK Comparison

Compare LGND & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$306.50

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo FS KKR Capital Corp.

FSK

FS KKR Capital Corp.

HOLD

Current Price

$11.12

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGND
FSK
Founded
1987
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
LGND
FSK
Price
$306.50
$11.12
Analyst Decision
Strong Buy
Hold
Analyst Count
7
8
Target Price
★ $256.29
$13.19
AVG Volume (30 Days)
172.3K
★ 1.5M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
★ 18.82%
EPS Growth
★ 2886.36
N/A
EPS
★ 1.63
N/A
Revenue
★ $141,102,000.00
N/A
Revenue This Year
$1.25
N/A
Revenue Next Year
$19.41
N/A
P/E Ratio
$192.70
★ N/A
Revenue Growth
★ 29.48
N/A
52 Week Low
$175.89
$9.72
52 Week High
$326.63
$16.31

Technical Indicators

Market Signals
Indicator
LGND
FSK
Relative Strength Index (RSI) 62.46 36.78
Support Level $286.99 $10.41
Resistance Level $322.06 $11.22
Average True Range (ATR) 9.45 0.24
MACD 3.06 -0.09
Stochastic Oscillator 77.12 28.08

Price Performance

Historical Comparison
LGND
FSK

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

Share on Social Networks: